Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma
University of Nebraska
University of Nebraska
City of Hope Medical Center
Barbara Ann Karmanos Cancer Institute
Vanderbilt-Ingram Cancer Center
University Health Network, Toronto
University of Louisville
Ohio State University Comprehensive Cancer Center
Vanderbilt University
SWOG Cancer Research Network
National Cancer Institute (NCI)
Vanderbilt-Ingram Cancer Center
Cytheris SA
University of California, San Francisco
Fred Hutchinson Cancer Center